Magnesium + Vitamin B6 for Bipolar Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mix of magnesium and vitamin B6 supplements for patients who have recently experienced their first episode of bipolar I disorder. The treatment aims to improve mood and reduce anxiety by supporting brain energy production and function.
Will I have to stop taking my current medications?
The trial requires that your psychiatric medications remain stable, meaning no changes in your current psychiatric medications for at least 2 weeks before the trial and no new psychiatric medications during the 4-week study period.
Is Magnesium + Vitamin B6 safe for humans?
How does the drug Magnesium Vitamin B6 differ from other treatments for bipolar disorder?
Magnesium Vitamin B6 is unique because it combines magnesium and vitamin B6, which have shown benefits in reducing stress and improving mental health in other conditions. This combination may offer a novel approach by potentially enhancing mood and quality of life through mechanisms like stress reduction and magnesium restoration, which are not typically targeted by standard bipolar disorder treatments.26789
Is the treatment Magnesium + Vitamin B6 effective for improving mental health in individuals with bipolar disorder?
Research suggests that magnesium combined with vitamin B6 can improve mental health and quality of life in stressed individuals, showing potential benefits for mood and anxiety. Additionally, vitamin B6 has been studied as an adjunctive therapy in bipolar disorder, indicating possible roles in mood regulation.2781011
Who Is on the Research Team?
Virginie-Anne Chouinard, MD
Principal Investigator
Mclean Hospital
Are You a Good Fit for This Trial?
This trial is for adults aged 18-45 with a recent diagnosis of bipolar I disorder, experiencing certain symptoms like depressed mood and anxiety. They should have moderate to severe stress but not be in a manic state, as shown by specific rating scales. Participants must be stable on their current psychiatric meds with no changes expected during the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Magnesium vitamin B6 or placebo three times daily for four weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Magnesium Vitamin B6
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor